INNVNasdaqServices-Health ServicesFiscal year ends June 30
InnovAge Holding Corp.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 9, 2026
$8.88+0.03 (+0.34%)
Close on Oct 19, 2026
- Market cap
- $1.21B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$3.55 (+66.45%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
InnovAge Holding Corp. grew revenue 15.9% to $989.71M over the twelve months to Jun 30, 2026. Free cash flow was $50.41M, up 89.5% from a year earlier.
Revenue
$989.71M
+15.9% vs. a year earlier
Operating income
$2.62M
TTM Q4 2026
Free cash flow
$50.41M
+89.5% vs. a year earlier
EPS, diluted
-$0.02
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.21B
- P/E ratio
- –
- Price to sales
- 1.22
- Price to book
- 5.12
- Dividend yield
- –
- Free cash flow yield
- 4.18%
Fundamentals
- Revenue
- $989.71M
- Net income
- -$2.54M
- EPS, diluted
- -$0.02
- Free cash flow
- $50.41M
- Book value per share
- $1.73
- Diluted shares
- 136M
Eight years at a glance
Fiscal years 2019 to 2026, USD
Revenue
$989.71M+15.9% YoY
Gross profit
$227.76M+48.2% YoY
Operating income
$2.62M
Net income
-$2.54M
EPS, diluted
-$0.02
Free cash flow
$50.41M+89.5% YoY
Reported period